Lombardi Comprehensive Cancer Center

Georgetown’s Lombardi Comprehensive Cancer Center is a resource for the community on many different levels. Locally, by serving the Washington, D.C., area, and also in Bergen County, New Jersey, through our research relationship with the John Theurer Cancer Center. Regionally, we are the only Comprehensive Cancer Center in Washington, D.C. Nationally and internationally, Georgetown Lombardi works to advance our mission with research and education collaborations on a global scale. Learn more about our community support: https://lombardi.georgetown.edu/community/

Community Engagement - Lombardi Comprehensive Cancer Center Georgetown University’s Lombardi Comprehensive Cancer Center is a resource for the community on many levels. Georgetown Lombardi is dedicated to serving the Washington, D.C., area and Bergen County, New Jersey, through our research relationship with John Theurer Cancer Center. These areas have som...

Why Biomarker Testing Should Happen Early for Every Patient With Colorectal Cancer | CURE Dr. John Marshall explains why biomarker testing should be done early in colorectal cancer to guide treatment and identify targeted therapies.

Georgetown’s Lombardi Comprehensive Cancer Center is committed to recruiting, educating, and developing the careers of outstanding basic and clinical cancer researchers. Through various degree programs, postdoctoral training, clinical fellowships, educational outreach and resources, and high school, undergrad, and post grad programs, Georgetown Lombardi is supporting the next generation of cancer researchers who will continue the fight against cancer. Learn more about Georgetown Lombardi programs: https://lombardi.georgetown.edu/education/

Education - Lombardi Comprehensive Cancer Center The Education and Training Program at Georgetown University’s Lombardi Comprehensive Cancer Center recruits, educates and trains the next generation of basic and clinical cancer researchers through a range of programs and initiatives designed to attract and engage individuals of all backgrounds an...

Georgetown joins the nation in celebrating Pride Month, honoring the legacies, accomplishments and contributions of our LGBTQIA+ community. https://bit.ly/4v6EpYE

At Lombardi Comprehensive Cancer Center, groundbreaking cancer research is powered by collaboration, innovation and a commitment to caring for the whole person. From breast cancer and hereditary cancer research to biomedical informatics and cancer aging studies, Georgetown Lombardi’s research centers are advancing discoveries that shape the future of prevention, treatment and survivorship. Learn more about our Research Centers and how their work is transforming lives across our communities: https://lombardi.georgetown.edu/research/centers/

Research Centers - Lombardi Comprehensive Cancer Center The Nina Hyde Center for Breast Cancer Research, established in 1989 as a tribute to a former fashion editor of The Washington Post, uses a collaborative, multidisciplinary approach to conduct cutting-edge breast cancer research.

On this , we honor all our fallen service members. We are grateful for their sacrifice and for the families who carry their legacy forward.

At Lombardi Comprehensive Cancer Center, cancer care goes beyond treatment. Guided by the value of cura personalis, or care of the whole person, healing includes innovative therapies, as well as therapeutic art, emotional support, and resources that care for patients and their families throughout every step of the journey. Learn about Georgetown Lombardi’s patient and family resources: https://lombardi.georgetown.edu/patient/patient-family-resources/

Patient and Family Resources - Lombardi Comprehensive Cancer Center Arts & Humanities Program The Georgetown Lombardi Comprehensive Cancer Center Arts & Humanities Program promotes an optimum life experience for patients, family members, and caregivers with activities, resources, education and environments that encourage a creative and constructive response to illn...

Researchers at Georgetown’s Lombardi Comprehensive Cancer Center have identified a mechanism that may help explain a key reason why older people experience worse outcomes from breast cancer. The study implicates RAGE (Receptor for Advanced Glycation End-products), a cell surface receptor that amplifies inflammatory signaling, and which also becomes increasingly active with metastatic progression. “Our study addresses a major gap by showing that aging dramatically increases breast cancer metastasis, and that this effect depends on RAGE, a receptor on the surface of cells that fuels inflammation,” says Barry Hudson, PhD, associate professor of oncology at Georgetown Lombardi and corresponding author for this article. The finding appeared in the Nature journal Communications Biology. Learn more: https://lombardi.georgetown.edu/news-release/study-reveals-why-breast-cancer-becomes-more-deadly-with-age/

Age and Breast Cancer Outcomes - Georgetown Lombardi Researchers at Georgetown Lombardi have identified a mechanism that may help explain why older people experience worse outcomes from breast cancer.